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There’s so many different worlds
So many different suns
And we have just one world
But we live in different ones
‐ Mark Knopfler, “Brothers in Arms”
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GLOSSARY OF TERMS
Anopheles – the species of mosquito that acts as a vector for the malaria parasite
Ariary – Madagascar’s official currency
Centre de Santé de Base – Basic health centers funded by the government
Endemic – when a disease exists permanently in a given region
Epiceries – small roadside shops that sell a range of goods, including a variety of
foods, drinks, and medicines
Epidemic – a sudden outbreak of a disease that causes simultaneous mass infection
Epidemiology – the study of the origins, distribution, and management of disease
Morbidity – the rate of infection
PaluStop – a CQ‐based malaria treatment distributed at a subsidized costs
throughout Madagascar
Pathology – the scientific study of disease, including its origins, growth, and effects
on human populations
Prophylaxis – preventative treatment for a disease
Vector – the animal species that carries and transmits an infectious disease; for
malaria, the Anopheles mosquito is the vector species

ACRONYMS
ACT – Artemisinin‐based combination therapy
AR – Ariary
CHW – Community Health Worker
CSB – Centre de Santé de Base
CQ – Chloroquine
5

DDT – Dichlorodiphenyl trichloroethylene
DRS – The Direction Régionale de la Santé du Planning Familiale et de la Protection
Sociale
GNP – Gross National Product
HIV/AIDS – Human Immunodeficiency Virus / Acquired Immune Deficiency
Syndrome
IMR – Infant Mortality Rate
ITN – Insecticide‐Treated Net
LLIN – Long‐lasting insecticidal mosquito net
MAP – The Madagascar Action Plan
MRDT – Malaria Rapid Diagnostic Test
NGO – Nongovernmental Organization
P. – Plasmodium
PEC – Prise en Charge
SP – Sulfadoxine‐pyrimethamine
USD – United States Dollars
PSI – Population Services International
WHO – World Health Organization
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INTRODUCTION
INTRODUCTION & RELEVANCE
Despite effective techniques for preventing and treating malaria, the malaria
burden in Madagascar remains quite high, particularly in rural areas where poor
villagers are more isolated from health services, and less likely to be able to afford
prevention methods or treatment. In response to this challenge, Madagascar’s
government has made malaria eradication a high priority, stating that it hopes to
reduce the incidence of malaria from its current level of 1,234,520 to 320,000 by
2012, and to eliminate the disease entirely by 2018. i Ultimately, though, it remains
to be seen if their efforts will be sufficient to meet these ambitious goals.
STATEMENT OF INTENT
For this paper, I attempted to gain an understanding of what resources are
available for preventing and treating malaria in rural villages in Madagascar. While
some of my objectives changed slightly over the course of the project, I was able, I
believe, to answer the following questions that gave direction to my planning and
research:
•

What is malaria? How is malaria transmitted?

•

How can malaria be prevented? How can malaria be treated?

•

What is the malaria burden in Madagascar?

•

What do people living in rural Madagascar know about malaria prevention
and treatment?

•

What resources are available in rural Madagascar to help prevent and treat
malaria?
7

•

What is Madagascar’s government doing to help reduce the incidence of
malaria?

•

What are nongovernmental organizations (NGOs) and doctors doing to help
reduce the incidence of malaria?

•

Will Madagascar be able to eradicate malaria in the future?

With these questions guiding my research, I attempted to gain insight into the
village‐level perception of malaria. As one Tanzanian agricultural worker explains,
“So‐called leaders do entirely too much talking to the peasants. No one ever wants
to listen to them.” ii With this idea in mind, I tried to see what insights talking to
rural Madagascar’s poor population—those who are most at risk for contracting and
dying from the disease—could lend to the malaria crisis in Madagascar, and the
efforts being made to address it. After analyzing the information I gathered through
conducting interviews with villagers, doctors, various NGOs, and government health
officials, I was able to draw my own conclusions about problems currently hindering
Madagascar’s efforts to control the disease, as well as what needs to be done if the
country is going to overcome these problems and accomplish its goal of eradicating
malaria by 2018.
THESIS
While the Malagasy government has a solid plan to eradicate malaria, current
efforts receive insufficient attention and financial resources. If the subsequent
discrepancies between the reality at the village level and the government’s strategy
are not addressed, malaria will continue to plague the country for many years to
come.
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DISCUSSION OF METHODOLOGY
Due to time constraints, it would have been impossible for me to conduct my
study in more than one region, or even in multiple villages. Instead, I focused on one
region, and one village in particular, and did a sort of case study that I believe is
more or less representative of the malaria situation in general in Madagascar. I
chose to conduct my case study in southeast Madagascar in the Atsimo Atsinanana
region where there are particularly high rates of malaria rates due to the wet
climate.
National & Regional Level:
I started my research in Antananarivo, the capital of Madagascar located in
the Central Highlands, where I interviewed doctors and read through books they
recommended in order to familiarize myself with basic background information
about malaria. Having this information proved very helpful for the next stage of my
research, when I traveled to Farafangana—the capital of the Atsimo Atsinanana
region—where I met with local health officials and doctors in an effort to gain an
understanding of the efforts being made at the regional level to combat malaria.
In Farafangana, I also worked closely with two NGOs: a local chapter of
Welthungerhilfe, a German organization dedicated to alleviating rural poverty, and a
local chapter of Inter Aide, a French organization that focuses on reducing the infant
mortality rate in Farafangana and the surrounding districts. Over the course of
many interviews with various employees of these two NGOs, as well as through
observing the operations of these organizations, I was able to learn a great deal
about the health issues in the region, particularly those relating to malaria.
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Village Level:
In the village of Anosikely, with the help of a translator, I conducted a general
survey in which I asked questions about malaria, particularly about what resources
are available to them for preventing and treating the disease. By establishing close
relationships with some of the villagers, I was able to get more personal information
about malaria‐related issues. My research in the village was both quantitative and
qualitative—I tried to gather not only facts and figures pertinent to my study, but
also anecdotal information that could help to improve my overall understanding of
malaria in Madagascar.
BIASES & OBSTACLES
For this paper, I used both primary and secondary sources to obtain the
information I needed. While ideally I would have preferred to use only primary
sources, due to time constraints—I had only four weeks to collect data and write the
paper—it became not only more practical and efficient, but also more reliable to
gather certain types of data through secondary sources. I did, however, always
make sure to use only those secondary sources that provided data consistent with
what I found through primary sources.
Obstacles arose when using primary sources as well. Throughout the course
of researching and writing this paper, I did my best to prevent my own opinions
from becoming apparent during interviews. Despite my best efforts, though, it is
probable that information I gathered was tainted in minor ways due to my own
biases. Furthermore, because I am a foreigner, villagers and health officials alike
often assumed that I was an aid worker researching malaria with the intention of
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helping in some way. While I was always sure to identify myself as an
undergraduate student and to explain the purpose of my research from the outset, I
have no doubt that in some instances, interviewees tried to give me answers they
thought I wanted to hear, or that they thought would benefit themselves in some
way.
In addition, interviews with primary sources proved to be somewhat difficult
due to a language barrier. For the most part, I also had no choice but to conduct
interviews in French, or in Malagasy with the help of a translator who could relay
the information back to me in French. While my French is strong enough to be able
to speak about malaria‐related issues, it is not sophisticated enough to distinguish
the nuances of the language, which ultimately might have contributed to tainted
questions or misinterpreted responses. When working with the translator, even
though I explained to him the importance of asking questions in such a way so as not
to encourage any particular answer, because I cannot speak Malagasy, it is
impossible for me to verify that he was in fact translating the questions in the same
manner as I was explaining them to him.
Finally, in order not to get skewed results about resources available in rural
villages, I intentionally did not contact or seek out any NGOs working on malaria‐
related projects in Farafangana or Anosikely before my arrival. However, for
logistical reasons, I was in touch with Welthungerhilfe before I went to Farafangana.
Even though they do not do any work specifically relating to malaria, they do have
projects in Anosikely, which was what allowed them to help me coordinate my stay
there. While their assistance was crucial for my being able to live in the village and
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conduct research there, their already established presence in Anosikely might have
affected the results of my inquiries in subtle, unforeseeable ways.

BACKGROUND INFORMATION: STUDY AREA
MADAGASCAR—A BRIEF HISTORY
The history of Madagascar, the world’s fourth‐largest island located around
250 miles off the coast of East Africa, is as complex and unique as its distinctive flora
and fauna, most of which is found no where else in the world. Despite the island’s
proximity to the east coast of Africa, home to some of the earliest human
settlements, human history in Madagascar is limited to relatively recent times.
Different theories about the origins and arrival times of the first residents exist,
though it is generally accepted that the island’s contemporary inhabitants are
descended from migrants who made their way to Madagascar from East Africa,
Arabia, and South‐East Asia, starting around 2000 years ago. While relations
between these different migrant groups have historically been marked by some
tension, in general, many aspects of these various ethnic groups have successfully
combined to create a unique Malagasy culture that blends African, Asian, and Arabic
elements.
Europeans did not arrive in Madagascar until the sixteenth century, after an
astray Portuguese merchant ship stumbled across the island. For the next several
hundred years, Madagascar continued to be a place of interest for European
merchants, slave traders, missionaries, and ultimately imperialists. While there was
much to attract the Europeans, such as a somewhat hospitable political regime and
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valuable natural resources, there was also much to discourage them. For example,
Madagascar’s climate was, and remains today, one in which tropical diseases
flourish: many settlers died of malaria and other tropical illnesses. However, the
disease burden was not enough to dispel European interest, particularly from Great
Britain and France.
Eventually this European interest evolved into European colonization. In
1896, after years of political contention and military clashes with Madagascar’s
government, France officially claimed Madagascar as a colony. Incidentally, around
this same time, it was a French military physician, Charles Louis Alphonse Laveran,
who originally identified the malaria parasite in the blood of soldiers while serving
in Algeria. By 1884, Laveran had suggested that mosquitoes were the vector for
malaria. Eventually, Laveran went on to receive a Nobel Prize for his contributions
to the understanding of malaria and other tropical diseases. Despite these
advancements, though, it was malaria and other tropical diseases, not Malagasy
soldiers, that proved to be the biggest killer of the French invaders. iii
CONTEMPORARY MADAGASCAR
While there were arguably some positive aspects of French colonial rule, the
overall effect was undoubtedly negative. Among other human rights outrages,
French leaders often used forced labor, essentially enslaving Malagasy men in an
effort to maximize the profits associated with the island’s natural resources. It was
not until after World War II when Madagascar, like many other colonized African
countries, started to experience serious political unrest and agitation against French
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rule. After years of battling for independence, which resulted in the deaths of over
89,000 Malagasy, iv Madagascar became officially independent from France in 1960.
Although not marked by the same sort of violent conflict that has plagued
many decolonized African nations, the years since Madagascar’s independence have
not seen significant economic growth or development. Indeed, with 85 percent of
the population living on less than $2 United States Dollars (USD) a day, and a per
capita Gross National Product (GNP) of $250 USD, Madagascar is now the fourth
poorest country in the world. v This level of severe poverty, which is particularly
pronounced in rural areas, renders Madagascar vulnerable to large‐scale public
health problems. In coping with malaria, Madagascar’s poor are particularly at risk.
As the World Health Organization (WHO) explains, “Malaria traps families and
communities in a downward spiral of poverty, disproportionately affecting
marginalized populations and poor people who cannot afford treatment or who
have limited access to health care.” vi
ANOSIKELY—RELEVANT DEMOGRAPHIC INFORMATION
Anosikely, with a population of about 1886 people, is a small fishing village in
the rural commune of Anosy Tsararafa, the District of Farafangana, Region of Atsimo
Atsinanana, in southeast Madagascar. vii The region and district’s capital,
Farafangana, is located about 25 kilometers south of Anosikely. As the largest town
in the area, Farafangana offers the nearest hospitals, post offices, banks, and
secondary schools.
The population of Anosikely is marked by the same sort of poverty that
plagues many other rural communities in Madagascar. Most of the village’s
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population relies on fishing as both the primary source of food and income, though
some families also grow rice or raise zebu. As a result of this subsistence lifestyle,
90 percent of the population lives on less than two dollars a day; 30 percent lives in
extreme poverty, meaning that they live on less than one dollar a day. About 90
percent of the population is illiterate, and an alarming 26 percent of the population
is chronically malnourished. viii Furthermore, resources in the town are limited:
there are two churches, one protestant and one catholic, three épiceries, and one
elementary school that is too small to hold all the students.
Regardless of these distressing statistics, there are many positive things to be
said about Anosikely. The people are warm and welcoming, and despite their
limited means, they are incredibly generous: if a family does not have enough to eat,
neighbors will often give away some of their food, even if they do not have enough
for themselves. Furthermore, while most of the villagers have very limited formal
education, they still have a good understanding of contemporary political issues, at
least at the village level. For instance, most villagers appreciate the importance of
using mosquito nets, and they realize they should have free access to them.
However, they also understand how “the system” works—they know that despite
what the government says, it will be a long time before distribution efforts reach
their tiny village. Overall, while the village does face real problems associated with
its poverty, there is hope for the future, and a general atmosphere not marked by
despair or anger, but by contentment and camaraderie.

BACKGROUND INFORMATION: MALARIA
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HISTORY & IMPACT
Throughout human history, malaria has played an important role in shaping
civilization. It has controlled where people live, forcing them into higher altitudes
where the disease does not survive; it has obliterated various armies invading sub‐
Saharan Africa, whose adolescent and middle‐aged soldiers had never before been
exposed to the disease; and it helped Europeans conquer the Americas, as they
brought the new disease with them from the Old World. Indeed, some scientists
estimate that no other single disease has done more to push humans forward in
evolution due to the high levels of mortality associated with the disease.
Unfortunately, despite effective treatments and reliable prevention methods,
malaria’s impact on the human population is not limited to the past: today, over 45
percent of the world is at risk for contracting malaria, ix resulting in a higher
incidence of the disease than any other infectious disease across the globe. x The
WHO estimates that more than 500 million people are infected every year, of which
approximately one million die. xi 90 percent of those mortalities are in sub‐Saharan
Africa, where malaria remains the number one cause of infant mortality. Indeed, in
Africa, one child under five dies from malaria every 30 seconds. xii In addition to
children, pregnant women are another demographic group for whom malaria poses
serious dangers. Pregnant women who become infected with malaria are at risk for
severe iron deficiencies and impaired fetal growth. As a result of malarial infection,
approximately 10,000 pregnant women and 200,000 of their infants die every
year. xiii
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As mentioned earlier, deaths rates associated with malaria are
disproportionately high among poor populations, as families cannot access
appropriate treatment or health care. However, not only are the poor more likely to
die from malaria, but the disease also has a substantial negative economic impact on
entire regions where it is endemic. In Africa, for instance, high infant mortality
rates, which can be attributed in large part to the malaria burden, reduce the rate of
growth by an estimated 1.3 percent. xiv In total, the financial repercussions of
malaria cost African countries an approximate $12 billion USD every year. xv
Furthermore, studies indicate that in the future, malaria may start to play an
even larger role, and affect places and people that have never before been exposed
to the disease. Some scientists estimate that “as our globe warms a degree or two,
the percentage of humans exposed to malarial parasites will rise from 45 to 60
percent.” xvi Indeed, if the malaria burden continues to increase at its current pace,
the number of deaths caused by malaria could double over the next 20 years. xvii
Despite these grim statistics, however, there is hope for the future. For
malaria to continue to thrive in any given area, it requires a dense human
population, a large mosquito population, as well as significant rates of transmission
of the malarial parasite from both the mosquitoes to humans, and from humans to
mosquitoes. Malaria has been successfully eradicated from North America, Europe,
and many places in the Middle East by interrupting these conditions. Only time will
tell, though, if humans will be able to overcome and potentially even eradicate
forever the disease that has been hindering growth and development for the past
50,000 years. xviii
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THE DISEASE—PATHOLOGY
Malaria is a potentially lethal disease caused by parasitic protozoa called
Plasmodium (P.). There are four different kinds of malaria parasites, P. falciparum,
P. vivax, P. ovale, and P. malariae, each of which causes a different kind of malaria. P.
falciparum, the most common strain of malaria, causes approximately 80 percent of
all malaria cases, and also is the cause for around 90 percent of all malaria‐related
deaths. xix The disease is found mostly in tropical and subtropical regions where its
vector, the female Anopheles mosquito, thrives. An Anopheles mosquito first
acquires the parasitic protozoa by biting a human who is already infected. After the
mosquito has fully digested the parasite, a process that takes approximately 30
minutes, the mosquito will start to pass on the parasite to the humans it bites.
PREVENTION
Currently, there is no vaccine available to protect against malaria. While
prophylactic medicines do exist, they are not effective for long‐term prevention.
However, prophylactic medicines are still a valuable option for people for whom
short‐term prevention is sufficient, such as for pregnant women, or for tourists
traveling to an endemic region. There are several drugs available for prophylactic
use, most of which can be used to treat malaria as well. For visitors to an endemic
region, popular medicines include Malaron, Cotrifazid, Lariam, and Plaquenil. For
pregnant women, the prophylaxis most commonly used is Sulfadoxine‐
pyrimethamine (SP), which requires only two doses taken at the start of the fourth
and fifth months of the pregnancy. These prophylactic medicines work essentially
the same way malaria treatment does, by cutting off the lifecycle of the Plasmodium
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parasite before it can develop fully in the bloodstream.
For people who live in malaria endemic regions the only effective prevention
method available is long‐lasting insecticidal mosquito nets (LLINs), which, when
used correctly, can help reduce the transmission of the parasite by up to 70
percent. xx Because Anopheles mosquitoes tend to feed at night, using these LLINs to
cover a bed is an effective way of preventing bites. In the past, insecticide‐treated
nets (ITNs), which are nearly two times as effective as their untreated
counterparts, xxi needed to be re‐treated every six months. Recent advancements,
though, have allowed for the production of these LLINs that continue to work for up
to five years.
Malaria prevention efforts also include limiting the growth of the Anopheles
mosquito population, which can be accomplished by spraying insecticides, or by
eliminating the breeding grounds for the mosquito by covering, poisoning or
draining standing water. In the past, such methods have helped to control or even
eradicate malaria in regions where it was once endemic. However, in recent years,
some mosquitoes have developed a resistance to Dichlorodiphenyl
trichloroethylene (DDT) and other pesticides, making this a less effective method by
which to control the growth of the mosquito population.
SYMPTOMS
Malaria can have a wide range of symptoms, including fever, chills, nausea,
iron deficiencies, and joint pain. The most common sign of malaria is recurring
onset of chills, followed by rigor and fever. Children who are suffering from malaria
often start to show signs of irregular posture, which can be indicative of serious,
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long‐term brain damage. However, symptoms of malaria vary from case to case, and
also vary depending on the strain of the disease.
The most dangerous and lethal kind of malaria is caused by the P. falciparum
parasite. With this type of infection, symptoms often do not start to show up until a
week or two after first contracting the parasite. Symptoms tend to be more severe,
and if left untreated, can lead to coma and death. This kind of malaria can develop
very quickly, leading to death within days or even hours. Chronic malaria, caused by
both P. vivax and P. ovale, can cause symptoms to recur months or years after the
first exposure, as the parasite remains in the liver even after treatment.
DIAGNOSIS
Essentially, malaria is diagnosed by identifying Plasmodium in a patient’s
blood. However, in regions where laboratory equipment is impractical or simply
too expensive, doctors often rely on symptomatic indicators to diagnose the disease.
While in the past this sort of symptomatic diagnosis was the only way to diagnose
malaria, new technologies are now available that yield much more accurate results.
In areas that have access to more sophisticated technology, the most reliable
way to diagnosis malaria is through microscopic examination of blood films.
Because each different kind of the Plasmodium parasite has its own unique
characteristics, using this sort of test, doctors can not only accurately diagnose
malaria, but can also more effectively treat the illness by identifying the specific
strain the patient has contracted. However, in many areas, access to this sort of
technology, or to someone who is trained in how to use it, is simply not a possibility.
In these areas, rather than simply rely on less accurate symptomatic indicators, it is
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now possible to use antigen detection tests, which require only a drop of blood on a
sort of testing strip to identify the presence of the Plasmodium parasite, similar to
the way a diabetic tests blood sugar levels.
These sorts of Malaria Rapid Diagnostic Tests (MRDTs), are often more
practical in rural areas because, as Dr. Liery Ranaivo explains, there is no need for a
laboratory, or for a specially trained physician. xxii These tests require only one drop
of blood drawn from a finger prick, and after approximately fifteen minutes, the
“dipstick” indicates whether the patient indeed has malaria. Because the test takes
so little time, patients can wait around for the results and receive the appropriate
treatment. However, these tests are not as accurate as the tests conducted under
microscopes, and they cannot distinguish between the different types of
Plasmodium.
TREATMENT
The different strains of malaria each require different sorts of treatments.
For instance, when infected with P. falciparum, patients must be hospitalized
immediately, whereas cases of P. vivax, P. ovale, or P. malariae can usually be treated
on an outpatient basis. In general, though, treatment consists of antimalarial drugs,
as well as supportive measures, including drugs to repress fevers, in order to help
alleviate some of the more uncomfortable or even life‐threatening symptoms. With
the appropriate treatment, nearly all malaria patients can make full recoveries.
There are several different drugs that are available to treat malaria. Until
recently, Chloroquine (CQ) was an effective and relatively cheap way to treat
malaria. Over the past several decades, however, P. falciparum has developed a
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resistance to the drug. This resistance, which has spread from Asia to Africa, means
that this cheap drug is no longer a viable option in most parts of the world. Apart
from CQ, there are several other drugs that still effectively treat malaria, including
artemether‐lumefantrine (known commercially as Coartem and Riamet),
artesunate‐amodiaquine, artesunate‐mefloquine, artesunate‐
sulfadoxine/pyrimethamine, atovaquone‐proguanil (known as Malarone), Quinine,
cotrifazid, doxycycline, mefloquine (known as Lariam), sulfadoxine‐pyrimethamine,
and hydroxychloroquine (known as Plaquenil).
In 2001, the World Health Organization officially started to recommend using
artemisinin‐based combination therapy (ACT) as the first option when treating
simple cases of malaria, especially in regions where CQ resistance is common.
These treatments blend several antimalarial drugs, including one derivative of
artemisinin—drugs derived from the plant Artemisia annua. Currently, artesunate
and artemether are two of the most widely used artemisinin derivatives found in
ACTs. These drugs are then used in conjunction with “partner drugs,” such as
mefloquine, lumefantrine, or amodiaquine. When used properly, ACTs are effective
over 90 percent of the time. xxiii Unfortunately, costs still remain a major obstacle to
their being used in many developing nations. Thus, even though many countries,
including Madagascar, have changed their official malaria treatment policies in
order to conform with WHO recommendations, because these new medications are
as much as 20 times more expensive than older drugs, ACTs are still out of reach for
many countries in which malaria is endemic. xxiv
MALARIA IN MADAGASCAR
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Malaria is a major public health problem in Madagascar—in 2005 there
were 1,234,520 presumed cases of the disease. xxv As in most African countries, it is
the single biggest killer of children under five years old. xxvi Indeed, it is responsible
for more consultations at Centre de Santé de Base (CSB)—the basic health clinics
funded by the government—throughout the country than any other infectious
disease. xxvii Despite government efforts, as well as the efforts of various NGOs,
malaria continues to cause thousands of deaths every year in Madagascar. xxviii
Madagascar’s malaria mortality also remains quite high—approximately 17.5
percent. xxix Furthermore, Madagascar always stands the risk of experiencing a
malaria epidemic, such as the one that took place from 1986 to 1988 during which
approximately 40,000 people living in Madagascar’s Central Highlands were
killed—a staggering one percent of the region’s population. xxx
Recently, Chloroquine resistance has finally started to appear in Madagascar.
The Malagasy government officially announced this resistance in October 2008,
though significant levels of resistance—in approximately 15 percent of cases—
started occurring as early as 2005. xxxi This new development in Madagascar’s
malaria situation is not surprising—CQ resistance started occurring in Asia a few
decades ago, and has been widespread throughout the rest of Africa for many years.
Nevertheless, this relatively new CQ resistance in Madagascar is unfortunate. Now
Madagascar must rely on other more expensive drugs in order to treat malaria
effectively.

THE SOLUTION
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FEASIBILITY
Madagascar currently finds itself at the start of an intensive 10‐year plan to
eradicate malaria from the island, a feat the government believes achievable due to
unprecedented levels of political engagement, as well as access to new technologies
to prevent and treat the disease. It is possible to eradicate malaria, as mentioned
earlier, by removing the conditions necessary for the parasite to continue to survive:
dense human population, a large mosquito population, and significant rates of
transmission of the malarial parasite both from humans to mosquitoes, and from
mosquitoes to humans. Because of its relative geographic insularity, Madagascar
has a unique opportunity to control these factors and eliminate the disease.
From 2002 to 2006, Madagascar implemented a trial malaria‐eradication
program on the small island of Ile Sainte Marie, located 40 kilometers off the east
coast of Madagascar. By supplying appropriate diagnostic tools, prevention
methods, and treatment options, and by ensuring coverage for more than 90 percent
of the population, the government was able to reduce significantly the incidence of
malaria. xxxii Now as these same techniques are being applied across the island, the
government hopes it will enjoy the same level of success as it did on Ile Sainte Marie.
NATIONAL LEVEL—THE M.A.P
In 2007 the Ravalomanana administration released its “Madagascar Action
Plan,” more commonly referred to as the MAP. The 113‐page booklet is full of facts
and figures about current problems in Madagascar, listed alongside milestones the
government plans to achieve by 2012. An entire section of the MAP is set aside for
defining goals pertaining to health, and within that section, a considerable portion is
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dedicated to listing goals pertaining to malaria. The first health challenge laid out by
the MAP is to “provide quality health services to all.” This means ensuring that
“adequate and quality health services will be increased to ensure easy access,
affordability and reliability,” that “[Madagascar] will have an educated population
which understands and uses quality health services and treatment options,” and
“there will be a partnership with Community Agents and the private sector at local
levels.” xxxiii
After these more general health‐related goals, the MAP focuses on more
specific goals, including those related to malaria. It states that the government
hopes to reduce the number of presumed cases of malaria from 1,234,520 to
320,000 by 2012. Furthermore, while in 2005, the mortality rate of malaria was
nearly 18 percent, by 2012, they hope to reduce the mortality rate to nine percent.
To accomplish this goal of “effectively controlling malaria,” the government—
specifically the Minister of Health—plans to “implement all available services for
effective control of malaria including indoor and outdoor spraying, distribution of
bed nets and adequate treatment,” as well as “link and coordinate national
campaigns in order to maximize coverage and effectiveness.” xxxiv
Because the MAP’s goals do not extend past 2012, no further details about
plans to eradicate malaria by 2018 are presented. Overall, the MAP is fairly vague,
does not give specific information about what the government actually plans to do
to accomplish its goals. For more specific details, it is necessary to examine the
eradication plan at the regional level. Much emphasis has been placed on the
importance of decentralizing the efforts to eradicate malaria, so as to give
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community doctors and health officials the leeway they need to apply effectively
their understanding of unique local conditions.
REGIONAL LEVEL—THE PLAN
The Direction Régionale de la Santé du Planning Familiale et de la Protection
Sociale (DRS) in Atsimo Atsinanana, a region where malaria is considered endemic,
has adopted a three‐tiered approach to eradicating malaria. While similar to the
approaches in other regions throughout the country, this approach is tailored
slightly to meet the specific needs of this region. Firstly, they are trying to manage
the dispersal of malaria in what they call the Prise en Charge (PEC), or “taking
charge” of the disease. This entails getting biological confirmation of all suspected
cases of malaria either through microscopic tests or MRDTs. It is important that
everyone who contracts a fever gets tested for malaria and given appropriate
treatment within the first 24 hours of symptoms. This will help to reduce rates of
transmission from humans to mosquitoes, interrupting one of the essential
conditions necessary for the continued existence of malaria in any given region. PEC
efforts also include the monitoring of success rates of various medicines to ensure
that resistance is not developing. If a drug has a 15 percent rate of resistance, the
state no long recommends using it, and no longer subsidizes the cost of that
particular drug.
The second part of the approach is focused on preventing new cases of
malaria. Prevention efforts are mostly directed at pregnant women and children
under the age of five—the two groups most vulnerable to malaria. Pregnant women
and children under five are all qualified to receive free, LLINs from their local
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hospitals or CSB. Recently, the state has also started subsidizing the costs of
Sulfadoxine‐pyramethamine, a prophylactic medicine for pregnant women given
away for free at the CSB or hospitals when they come in for their pre‐natal visits.
Thirdly, the regional office is working to increase general awareness about
malaria through social mobilization campaigns, particularly geared towards rural
populations. As Dr. Razafimaharo explains, in order for the other two aspects of
their approach to work, it is crucial that everyone in the region has at least a basic
understanding of malaria: how it is transmitted, how to prevent it, how to recognize
its symptoms, where to get treatment, etc. The regional office tries to disseminate
this kind of information in several different ways, so as to access various sectors of
society. In more recent years, the radio has also become a particularly effective way
of transmitting these messages to a mass audience, as more and more people now
own radios, even in rural villages. xxxv
THE TIMETABLE
In order to gauge its progress, the Malagasy government has developed a
timetable that lays out the four different stages towards the eradication of malaria.
The first stage, the Preparatory Phase takes place from 2007 until 2008. This phase
consists of examining the distribution of the disease and evaluating the
administrative capacity and operations of the eradication programs. This
Preparatory Phase also allows time for the public and private sectors to be
reoriented and reorganized in such a way so as to work together more efficiently to
accomplish their common goal of eradicating malaria. Following this first step
comes the Attack Phase, which lasts from 2008 until 2012. During this stage, efforts
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are focused on the interruption of the transmission of malaria by putting into place
effective interventions with 100 percent coverage. Essentially, this is the stage
during which the DRS’ three‐tiered approach is applied.
Once evaluation shows that malaria transmission has been interrupted, the
Consolidation Phase begins. During this phase, which lasts from 2012‐2017, the
government focuses on reinforcing surveillance to detect and eliminate all cases of
malaria and prevent the reintroduction of sources of infection. Finally, in 2018 once
elimination has been fully achieved, the Maintenance Phase begins. During this
stage, efforts are focused exclusively on malaria surveillance to ensure that the
disease is not introduced to the country. xxxvi
THE RESOURCES
LongLasting Insecticidal Nets:
Madagascar’s government and other various NGOs have worked to supply
CSB’s all across the country with the new technologies now available to prevent and
treat malaria more effectively. As of 2006, in cooperation with various international
NGOs, the government of Madagascar pledged to provide free LLINs to pregnant
women and children under the age of five. Pregnant women can obtain these nets
during their pre‐natal exams at any CSB or hospital.
As mentioned earlier, these nets can be extremely effective at preventing
malaria transmission. Furthermore, recent studies also indicate that it is best to
give these LLINs away for free. In the past, many believed that recipients of free
nets would not appreciate their purpose. In 2007, however, in response to excellent
results in a trial–program conducted in several sub‐Saharan African countries, the
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WHO officially renounced this “responsible ownership” theory and started to
encourage nets to be given away for free. In Kenya, when nets were given away for
free, the WHO noticed a 44 percent decrease in infant mortality in families who had
received the free LLINs. In Zanzibar, malaria‐related deaths decreased by an
astonishing 95 percent after nets were given away for free. xxxvii Indeed, distributing
free LLINs has proven to be both an incredibly effective and cost‐efficient way to
reduce the incidence of malaria.
Malaria Rapid Diagnostic Test:
Malaria Rapid Diagnostic Tests allow rural communities to have access to
reliable malaria diagnosis. Now, Madagascar’s government has worked to ensure
that these MRDT are available in all CSB and hospitals throughout the country. This
is an important step towards getting control over the disease. As Dr. Liery explains,
for every approximately ten people she tests for malaria, perhaps only one or two
actually test positive. In the past, those other eight people would probably have also
been treated for malaria. This kind of unnecessary treatment not only means that
the real source of the fever is being ignored, but also that by unnecessarily exposing
patients to new medications, their potential future malarial infections are more
likely to develop resistance to these new drugs. xxxviii
Artemisininbased Combination Therapy:
In response to the WHO’s recommendation to use artemisinin‐based
combination therapy when treating all simple cases of malaria, as well as in
response to the growing problems associated with CQ resistance in Madagascar, the
government now provides all hospitals and CSB with ACTs to be distributed for free
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whenever a patient tests positive for malaria. ACTs are easy to administer: the
treatment for children consists of one dose a day for three days. This easy‐to‐follow
treatment plan favors better adherence by patients, which in the long run can lead
to reduced rates of resistance. Studies also show that “ACTs produce the fastest
clinical recovery because the artemisinin derivatives kill parasites more rapidly
than any other antimalarial known.” xxxix Furthermore, by essentially treating
patients with several different drugs at the same time, the risk of artificially
selecting for mutants in the parasite population is significantly reduced, meaning it
is a lot less likely that resistance will develop.
INTER AIDE
In addition to the role of the government in working to eradicate malaria,
NGOs also play a large role. In Farafangana, Inter Aide, a French organization, is the
only NGO that focuses on malaria.
Description of Organization:
Inter Aide has been working in southeast Madagascar for the past 12 years,
when they started a program in Manakara to help ensure all of its residents had
access to clean drinking water. Around eight years ago, in response to alarmingly
high infant mortality rates—around 200/1000 in the region, xl as opposed to around
5/1000 in most European countries xli —Inter Aide developed a program that tried to
address two of the main causes of infant mortality in the region: malaria and
diarrhea. Essentially, in the Manakara region, Inter Aide uses a sort of Community
Health Worker approach to teach villagers how to avoid and how to deal with these
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two preventable and treatable illnesses that are responsible for the unnecessary
deaths of so many children.
Then in May 2007, Inter Aide conducted its own health survey in the 20 rural
communes surrounding Farafanana. They learned that in this area, the infant
mortality rate is 182/1000, xlii almost two times the national average of 94/1000. xliii
In response to this, Inter Aide quickly began the process of replicating the health
program that had worked so successfully in the Manakara district in Farafangana.
Their Techniques:
Inter Aide uses a sort of three‐pronged approach to addressing these two
health issues. Firstly, they train and pay the aforementioned CHWs who each go live
in different villages for six months at a time. When the CHWs first arrive in their
villages, they present themselves to local traditional and administrative authorities,
distribute the results of their earlier surveys to all the villagers, and explain to
everyone the methods and objectives of the program. After building this
relationship, the CHWs run a series of six workshops directed primarily towards
mothers. Four of these workshops address diarrhea related issues, and two are
centered around malaria prevention and treatment. Because most of the villagers
they work with are illiterate, the CHWs use illustration booklets and games in order
to disseminate the information.
Secondly, from these groups of mothers who attend the workshops, some of
the more engaged women are chosen to receive additional training from the CHWs.
For malaria, they learn how to recognize the symptoms, and for basic cases, they are
given medications to treat the children. Finally, Inter Aide also helps to combat
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malaria by subsidizing part of the cost of LLINs, reducing the cost to 2,000AR for
pregnant mothers and children. Not only is the price subsidized, but also the
mosquito nets can be ordered in the village and delivered by the CHWs. By
personally delivering the nets, Inter Aide effectively eliminates one of the main
obstacles for villagers in getting the nets. xliv
While the program in the Farafangana district has not been around long
enough to know whether it has been successful, in the villages surrounding
Manakara, where Inter Aide has been using the same approach for almost eight
years, this approach already has some well‐established results. For instance, over
30,000 LLINs have been distributed in 150 villages, and in villages where Inter Aide
had placed CHWs, the infant mortality rate dropped to 66/1000 compared to a rate
of 137/1000 in villages where Inter Aide had not staged an intervention. xlv

THE “REALITY”—VILLAGE FINDINGS
Despite the positive indicators for malaria eradication, the national‐ and
regional‐level plans, and the history of success of Inter Aide, in Anosikely, the
malaria situation is far from being under control. There exist large gaps between
the eradication plans proposed by the government, and the reality at the village
level.
VILLAGE FINDINGS
In Anosikely, approximately 33 percent of households reported having at
least one member who had malaria in the past year. Infant morality rates in the
village are alarmingly high: in the past year, nearly 27 percent of households lost at
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least one child under the age of five. Furthermore, nearly 26 percent of households
lost at least one child under the age of one in the past year. The most significant
cause of this high infant mortality rate is malaria. An approximate 69 percent of
households reported that their children sleep under mosquito nets, while an
estimated 31 percent do not, rendering them vulnerable to the transmission of the
disease. Furthermore, approximately 31 percent of pregnant women did not use
mosquito nets during their pregnancy, or receive prophylactic medicine. xlvi
Self‐medicating is a reality in the village of Anosikely, as only 35 percent of
households buy their medicines at the CSB II in Tsararafa, whereas 41 percent
choose to buy their medicines at épiceries, and 17 percent from traditional healers.
As for where the villagers choose to get treatment, only 58 percent of households
get treatment for serious illnesses at the CSB. An alarming 28 percent still prefer to
get treated by traditional healers. The self‐medication phenomenon associated with
limited use of the CSB in Tsararafa by the population of Anosikely is consistent with
the percentage of households in which children did not receive the appropriate
treatment for malaria—an alarming 61 percent. This practice will only increase the
rates of infant mortality caused by malaria if it is continued at its current rate. xlvii
Despite these statistics, villagers seem to have a good understanding of
malaria, how it is transmitted, how to prevent it, and the most effective way to treat
it. Therefore, there must be other factors influencing their decisions not to get
treatment, medicines, or mosquito nets. Many villagers attributed these decisions
simply to the inaccessibility of resources. Indeed, it is usually impossible to buy
mosquito nets or treatment in the three épiceries located in the village. Instead,
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villagers have no choice but to travel to the nearest CSB in order to receive any sort
of reliable health treatment.
CENTRE DE SANTÉ DE BASE
The closest CSB to Anosikely is in Tsararafa, around nine kilometers away.
As most villagers do not own bikes, let alone any sort of motor transportation, this
means that a trip to the doctor is a daylong affair, requiring them to make the nearly
three‐hour walk both to and from the CSB. As many villagers reported, this is
particularly difficult for the people who most need to get to the CSB—for pregnant
women who wish to receive their free mosquito nets or their free prophylaxis, or for
sick children who need to get tested for malaria at the CSB in order to qualify to
receive the free medicine. Unfortunately, this sort of inaccessibility of reliable
healthcare in Anosikely is common in Madagascar: an estimated 65 percent of the
population lives more than five kilometers from any CSB. xlviii
Furthermore, as many villagers reported, getting to the CSB did not ensure
that they would be treated: there are usually long lines to see the one doctor who
works there, and she often leaves to spend long‐weekends in Farafangana. In
response to these sorts of issues, the government has tried to initiate a Community
Health Worker program, so as to have a kind of hospital representative in each of
the villages who can distribute mosquito nets, diagnose and treat simple cases of
malaria, and refer people to the CSB who need to get more advanced treatment.
However, the CHW in Anosikely did not have any sort of formal training, or access to
mosquito nets or medicine. His role, as he defined it, is to encourage people to go to
the CSB whenever they need to buy mosquito nets or medicine, or need any other
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sort of medical care. xlix Thus, there are obvious discrepancies even between the
plan at the CSB in Tsararafa, and the reality in the village.
Sadly, inaccessibility of proper medicines in the village was not the only
problem: one source privy to the inner workings of the health care system explained
that since the government made the decision no longer to use CQ when treating
malaria cases, but instead to treat solely with ACT, they have not been effective at
distributing the new medications. Instead, stocks of CQ sit unused on shelves in CSB
while doctors wait for the new medications to arrive. Often when sick children
come in, rather than at least trying to treat with the old medications, doctors turn
families away, letting children go untreated even when a medication is available that
still works in 85 percent of cases. l
CORRUPTION
At the CSB in Tsararafa, there did seem to be an adequate stock of the new
ACT medicines that the government recommends using to treat simple cases of
malaria. However, every villager interviewed throughout the course of this project
insisted that they were charged money for treatment at the CSB. Depending on the
severity of the fever, they were charged more money, ranging from $2000AR to
$12,000AR. While the doctor at the CSB maintained that the medicines were given
away for free—indeed, they are supposed to be free—the consistency with which
villagers reported their having to pay a fee indicates that corruption is in fact a
problem at the CSB.
Other evidence also leads to this same conclusion. For instance, when asked
why so many people choose to buy less effective medicine in the épiceries, rather
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than receive free, effective medication from the CSB, a phenomenon the doctor
herself reported, she struggled to find an answer. It would be uneconomical for
villagers—90 percent of whom live on less than two dollars a day—to buy medicine
if instead they could get medicine for free. This is particularly true in Anosikely,
since for the people who live there, getting any medicine at all—whether the
effective medicine from the CSB or the less effective medicine from épiceries—
means traveling nine kilometers to Tsararafa. Thus, such high rates of self‐
medication, as mentioned before a total 58 percent, indicate that villagers are
charged fees for medications that are supposed to be free.
While no exact numbers exist, anecdotal evidence suggests that this sort of
corruption is alarmingly common, and is widely accepted simply as a part of the
health care system. Indeed, many villagers seemed to know that the medications
they paid for were supposed to be free, yet were not surprised when they charged a
fee. Although it is easy to fault individual doctors for this seemingly selfish
behavior, the enormity of the problem indicates that something more profound than
human greed is to blame. Many doctors are overworked, and too much pressure is
put on them to ensure the health and wellbeing of quite a large group of people.
Indeed, the one doctor who works at the CSB in Tsararafa is essentially responsible
for all of the district’s 19, 817 residents. li
PALUSTOP
As a result of these marked up prices, many poor families have no choice but
to buy PaluStop in the épiceries, a CQ‐based medicine distributed at a subsidized
cost by Population Services International (PSI), an American NGO. However,
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because resistance has developed to CQ, this treatment is no longer effective
approximately 20 percent of the time. This resistance has developed in large part
due to misuse of the medicines: often, people will take the medicine until they feel
better, and then save the rest for the next time they contract a fever. Not only does
this misuse help to build up a resistance, but it also makes patients more likely to
develop serious, sometimes lethal cases of malaria. Furthermore, once patients
have self‐treated, if they go into the CSB to get tested for malaria, the tests will come
back negative. While it is hard to fault people for trying to treat themselves,
particularly since for many it is the only affordable treatment option, in the long run,
this sort of behavior might be worse for their health.
MOSQUITO NETS
Even though mosquito nets are supposed to be free in this region for
pregnant women and children under five, all of the CSB and hospitals, even those in
Farafangana, no longer have any in stock. Instead, people must purchase their own
LLINs, which can cost from $2000AR to $3500AR, a price that is reduced due to
subsidies provided by various NGOs. While this fee—approximately $1.75 USD—
may seem nominal by Western standards, to many villagers in Anosikely this cost
puts mosquito nets out of reach.
Even if the CSB in Tsararafa had mosquito nets in stock, though, it would still
be very difficult for many women to get them. In order to receive the LLINs,
pregnant women would have to travel the nine kilometers to Tsararafa for a pre‐
natal exam, a long enough trip for a completely healthy woman, let alone for a
woman four months pregnant. Indeed, approximately 30 percent of pregnant
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women in Anosikely do not visit the CSB for their pre‐natal care, but instead choose
to be treated by the traditional midwives available in the village. lii So ultimately,
while most women in the village understand the importance of using a mosquito net
during their pregnancy, many still find themselves unable to get them.

ANALYSIS & CONCLUSION
SUGGESTIONS
In order for Madagascar to accomplish its goal of eradicating malaria by
2018, in addition to addressing more complex infrastructural and developmental
issues, there are several specific actions the government should take. First, if any of
their other efforts are going to succeed, they must address the issue of doctors
taking bribes for medications that are supposed to be free. It is also probable that
once mosquito nets are again distributed for free at the CSB, the same sort of
problems will arise. Money invested in subsidizing the costs of those medicines and
mosquito nets is essentially being wasted, since the poor—the people whom those
subsidies are meant to help—are often still forced to pay.
Corruption is a problem so engrained into parts of Malagasy society that
many have come to accept it as a part of daily life. While this makes it more difficult
to overcome, in the short‐run simply by improving the living conditions of doctors
who are assigned to rural areas, and by ensuring that they receive adequate
compensation for their work, Madagascar could at least ensure that doctors are not
taking bribes just to meet their basic needs. In addition, systems need to be put in
place to monitor doctors in rural areas. It was not difficult to find out that the
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doctor at the CSB in Tsararafa was corrupt, yet no one was doing anything about it.
Local officials responsible for the CSB are thus either unaware of the problem, or
choose simply to overlook it. At times, the health care system in Madagascar seems
so disorganized that it is also certainly possible that there is no one who is directly
responsible for monitoring this CSB, or who realizes that he is supposed to be
monitoring it. Either way, the health care system needs to be restructured so that
such problems do not go unnoticed, and cannot just be ignored. This doctor should
have to answer to someone, and it should be someone who recognizes her “fee” for
what it is: stealing from the poor.
Secondly, if Madagascar hopes to eliminate malaria by 2018, the government
needs to make good on its promise to distribute free mosquito nets for pregnant
women and children under five. Giving these nets away for free would significantly
improve Madagascar’s efforts to eradicate malaria. However, simply giving away
the LLINs at hospitals and CSB is not adequate. Community Health Worker
programs need to be promoted throughout the country, and regulated at least at a
regional if not national level, so as to ensure that all CHWs receive adequate training
and compensation. CHWs should be informed about malaria prevention techniques,
and should also know how to diagnose and treat simple cases of the disease. Then,
by giving these CHWs access to LLINs, MRDT, and ACT kits, the CHWs can effectively
narrow the large gap that currently exists between health resources and isolated
rural villages. While there are certain hazards associated with this sort of program,
such as resources being distributed unfairly or inappropriately, in the past, properly
implemented CHW programs have proven to be a remarkably efficient way of giving
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rural communities access to basic health care. Indeed, the success of organizations
like Inter Aide is a strong indicator that CHW programs can go a long way towards
improving rural health.
Ultimately, though, if malaria is ever to be eradicated from Madagascar, more
money needs to be invested in both prevention and treatment efforts. Indeed, many
of the aforementioned suggestions are already in place in theory, but have fallen
apart due to inadequate funding. While technically only Madagascar’s government
can be blamed for lack of sufficient funding, morally, the entire international
community is at fault. Malaria does not get the attention at the international level it
deserves, in large part due to the fact that it has been eradicated in nearly all
developed countries, including in Western Europe and the United States. If more
people in developed nations were aware of how devastating the disease is, and how
easy it is to prevent and treat, malaria efforts would get the financial support it
needs.
CONCLUSION
For the people of Anosikely, such theoretical discussions about the possibility
of eradicating malaria are irrelevant. What matters to them is that their wives,
mothers, children and babies are dying, and they feel there is nothing they can do
about it. Their options are, in fact, fairly limited: many simply cannot afford the
mosquito nets they know might help to prevent the disease, or the treatment they
know might save their lives.
Unfortunately, there is no quick fix to the malaria crisis facing Madagascar
today. However, there are solutions that, carried out over the long‐term, could lead
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to eradicating malaria from the island. Scientific advancements just over the past
few decades have made it possible to control the disease, both through simple and
effective prevention and treatment techniques. If the Malagasy government and the
rest of the international community take appropriate action, malaria could be
eradicated from Madagascar by 2018. We have the tools and resources we need to
address this devastating problem; time will tell if we will use them well enough to
help the villagers of Anosikely and others like them throughout Madagascar.
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